VEMLIDY 25 mg/1
tenofovir alafenamide · TABLET · Gilead Sciences, Inc.
Vemlidy is an oral tablet containing tenofovir alafenamide, used to treat chronic hepatitis B infection in adults. It works by reducing the amount of hepatitis B virus in your body.
Key Facts
- Brand Name
- VEMLIDY
- Generic Name
- tenofovir alafenamide
- NDC Code (Product)
61958-2301- Manufacturer
- Gilead Sciences, Inc.
- Strength
- 25 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- NDA208464
- Marketing Start
- 11/10/2016
Recall History
No Recall HistoryFrequently Asked Questions
What is VEMLIDY used for?
Vemlidy is an oral tablet containing tenofovir alafenamide, used to treat chronic hepatitis B infection in adults. It works by reducing the amount of hepatitis B virus in your body.
Is VEMLIDY a controlled substance?
VEMLIDY is not classified as a controlled substance by the DEA.
What is the generic name for VEMLIDY?
The generic name for VEMLIDY is tenofovir alafenamide. There are no other listed brand versions of tenofovir alafenamide.
What is the NDC code for VEMLIDY 25 mg/1?
The NDC (National Drug Code) for VEMLIDY 25 mg/1 is 61958-2301, listed by Gilead Sciences, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)